Effects of Escitalopram on Markers of Bone Turnover: A Randomized Clinical Trial

CONTEXT: Recent observational studies have suggested that the use of selective serotonin reuptake inhibitors is associated with an increased fracture risk and an accelerated bone loss, although conflicting results have been reported. Furthermore, because many of these studies have been performed in...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Diem, Susan J., Joffe, Hadine, Larson, Joseph C., Tsai, Joy N., Guthrie, Katherine A., LaCroix, Andrea Z., Ensrud, Kristine E., Freeman, Ellen W., Leder, Benjamin Z.
Format: Artigo
Idioma:Inglês
Publicat: Endocrine Society 2014
Matèries:
JCEM Online: Brief Reports
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4154080/
https://ncbi.nlm.nih.gov/pubmed/25014001
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/jc.2014-2288
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars